CIPRO - ciprofloxacin hydrochloride and hydrocortisone
Navigation: NDC > Supplier starting with: A > ALCON LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0065-8531 |
| Proprietary Name: | CIPRO |
| Suffix: | HC |
| Non-Proprietary Name: | ciprofloxacin hydrochloride and hydrocortisone |
| Dosage Form: | SUSPENSION |
| Method: | AURICULAR (OTIC) |
| Original Marketing Date: | 15-03-1999 |
| Category Name: | NDA |
| Application Number: | NDA020805 |
| Labeler: | ALCON LABORATORIES, INC. |
| Substance Name: | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE |
| Active Numerator Strength: | 2; 10 |
| Active Ingredient Unit: | mg/mL; mg/mL |
| Pharm Classes: | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| DEA Schedule: |